SOU-001

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameSOU-001
Drug Alias NameDRP 001AA 10020Stress incontinence therapy - Arachnova/SoseiDRP-001SOU-001 +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAlpha-1a adrenergic receptor antagonistsAlpha-1b adrenergic receptor antagonists
TargetsAlpha-1a adrenergic receptorAlpha-1b adrenergic receptor
Therapy Area/IndicationsUrinary Incontinence, Stress
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesSosei Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSosei Inc
Active IndicationsN/A
Inactive IndicationsUrinary Incontinence, Stress

Other Information

ATC CodeN/A
Related LinksN/A